Rasagiline is a monoamine oxidase type-B inhibitor used seeing that monotherapy or furthermore to levodopa in the treating Parkinsons disease. open to certified users. worth?=?0.315). Pharmacoeconomic Research of Rasagiline Hudry et al. [42] carried out a study to judge the cost-benefit of rasagiline and entacapone as adjunctive therapy to levodopa weighed against levodopa only in… Continue reading Rasagiline is a monoamine oxidase type-B inhibitor used seeing that monotherapy